192573-75-4

Upstream product

• 5736-89-0 1-(4-butoxyphenyl)ethan-1-one 
• 109-94-4 formic acid ethyl ester 

Downstream Products

• 881735-41-7 2,4,6-tris[3-(4-butoxyphenyl)pyrazol-1-yl]-1,3,5-triazine 
• 1107059-52-8 Ag(3-(4-(butoxy)phenyl)pyrazole)2PF₆ 
• 679400-92-1 cyclo-tris(μ-[3-(4-butoxyphenyl)-1H-pyrazolato-κN(1):κN(2)])trigold 
• 679400-95-4 cyclo-tris(μ-[3-(4-butoxyphenyl)-1H-pyrazolato-κN(1):κN(2)])trisilver 
• 192573-85-6 [Rh(N₂C₃H₂C₆H₄O(CH₂)3CH₃)(C₈H₁₂)]2 

Relevant academic research and scientific papers

Pyrazole and Isoxazole Derivatives as New, Potent, and Selective 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Synthase Inhibitors

In a previous paper, we reported the N-hydroxyformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Despite its attraction as a potential therapeutic agent for cerebral diseases, the preparation of an injectable formulation

3-[4-Phenoxyphenyl]pyrazole (Hpzpp) and 3-[4-butoxyphenyl]pyrazole (Hpzbp) in rhodium chemistry crystal structures of 3-[4-phenoxyphenyl]pyrazole, [Rh(μ-pzpp)(COD)]2·1/2CH2Cl2 and [Rh(μ-pzbp)(COD)]2

The novel pyrazoles containing 3-[4-phenoxyphenyl] (pp) and 3-[4-butoxyphenyl] (bp) substituents, Hpzpp and Hpzbp, have been synthetized and characterized, and the crystalline structure of 3-[4-phenoxiphenyl]pyrazole (Hpzpp) is also reported. Rh(I) compounds [Rh(Cl)(HpzR)(LL)] and [Rh(μ-pzR)(LL)]2 (LL = NBD, COD, 2CO; R = pp, bp) have been prepared in order to explore the influence of the alkoxy- or aryloxyphenyl substituents on the pyrazol ring of some features such as the presence of dynamic processes or the preference of determined isomers in the complexes. The molecular structures of complexes [Rh(Cl)(HpzR)(LL)] and [Rh(μ-pzR)(LL)]2 (LL = NBD, COD, 2CO; R = pp, bp) have been studied by IR and 1H and 13C NMR spectroscopies. 1H NMR spectra of compounds [Rh(Cl)(HpzR)(LL)] (LL = NBD, COD, 2CO; R = pp, bp) indicate that the presence of a metallotropic equilibrium only depends on the steric characteristics of the ancillary ligands. On the other hand, complexes [Rh(μ-pzR)(CO)2]2 (R = pp, bp) are formed as a mixture of the head-to-head (H-H) and head-to-tail (H-T) configurational isomers. By contrast, [Rh(μ-pzR)(LL)]2 (LL = NBD, COD; R = pp, bp) have been obtained as only one isomer in both the solid state and the solution. The crystalline structures of complexes [Rh(μ-pzpp)(COD)]2·1/2-CH2Cl2 and [Rh(μ-pzbp)(COD)]2 have been solved, showing the presence of the H-T configurational isomer in both cases. The 1H NMR spectra of [Rh(μ-pzR)(LL)]2 (LL = NBD, COD, 2CO; R = pp, bp) show that the ortho protons of the C6H4 group of the substituents on the pyrazol ring are considerably deshielded. Furthermore, the X-ray structures of [Rh(μ-pzpp)(COD)]2·1/2CH2C12 and [Rh(μ-pzbp)(COD)]2 complexes show an Rh-H(ortho) distance of ca. 2.7 A, characteristic of a weak preagostic interaction.